These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2847644)
1. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. Bermudez LE; Young LS Antimicrob Agents Chemother; 1988 Aug; 32(8):1149-53. PubMed ID: 2847644 [TBL] [Abstract][Full Text] [Related]
2. [Activity of azithromycin and roxithromycin alone or in combination against Mycobacterium avium and Mycobacterium xenopi]. Gevaudan MJ; Bollet C; Mallet MN; Gulian G; Tissot-Dupont H; de Micco P Pathol Biol (Paris); 1990 May; 38(5):413-9. PubMed ID: 2164181 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Bermudez LE; Wu M; Petrofsky M; Young LS Infect Immun; 1992 Oct; 60(10):4245-52. PubMed ID: 1328056 [TBL] [Abstract][Full Text] [Related]
4. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. Bermudez LE; Martinelli J; Petrofsky M; Kolonoski P; Young LS J Infect Dis; 1994 Mar; 169(3):575-80. PubMed ID: 8158029 [TBL] [Abstract][Full Text] [Related]
5. Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages. Rastogi N; Labrousse V; Bryskier A Antimicrob Agents Chemother; 1995 Apr; 39(4):976-8. PubMed ID: 7786006 [TBL] [Abstract][Full Text] [Related]
6. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex. Rastogi N; Goh KS; Bryskier A Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850 [TBL] [Abstract][Full Text] [Related]
7. Stimulation with cytokines enhances penetration of azithromycin into human macrophages. Bermudez LE; Inderlied C; Young LS Antimicrob Agents Chemother; 1991 Dec; 35(12):2625-9. PubMed ID: 1667256 [TBL] [Abstract][Full Text] [Related]
8. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde JL; Pocidalo JJ Antimicrob Agents Chemother; 1991 Jul; 35(7):1356-9. PubMed ID: 1656860 [TBL] [Abstract][Full Text] [Related]
9. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. Bermudez LE; Young LS J Leukoc Biol; 1990 Jul; 48(1):67-73. PubMed ID: 2113563 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. Denis M J Leukoc Biol; 1991 Apr; 49(4):380-7. PubMed ID: 1900522 [TBL] [Abstract][Full Text] [Related]
11. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774. Yajko DM; Nassos PS; Sanders CA; Hadley WK Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581 [TBL] [Abstract][Full Text] [Related]
12. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969 [TBL] [Abstract][Full Text] [Related]
13. Potential role of roxithromycin against the Mycobacterium avium complex. Young LS; Bermudez LE; Wu M; Inderlied CB Infection; 1995; 23 Suppl 1():S28-32. PubMed ID: 7782113 [TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of clofazimine alone and in combination with amikacin, roxithromycin, rifampicin and rifapentine against Mycobacterium avium-intracellulare]. Casal Román M; Rodríguez López F; Villalba Montoro R; González Requero AI Enferm Infecc Microbiol Clin; 1989 Oct; 7(8):432-5. PubMed ID: 2490859 [TBL] [Abstract][Full Text] [Related]
15. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma. Bermudez LE J Immunol; 1993 Mar; 150(5):1838-45. PubMed ID: 8436819 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. Bermudez LE; Young LS J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450 [TBL] [Abstract][Full Text] [Related]
17. 1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF. Bermudez LE; Young LS; Gupta S Cell Immunol; 1990 May; 127(2):432-41. PubMed ID: 2183943 [TBL] [Abstract][Full Text] [Related]
18. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. Chang HR; Pechère JC Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140 [TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro synergistic effect between clarithromycin or azithromycin in combination with amikacin against Mycobacterium intracellulare. Zhang Z; Lu J; Du Y; Xie F; Wang Y; Sun B; Pang Y J Glob Antimicrob Resist; 2019 Sep; 18():183-186. PubMed ID: 30953831 [TBL] [Abstract][Full Text] [Related]
20. Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. Onyeji CO; Nightingale CH; Tessier PR; Nicolau DP; Bow LM J Infect Dis; 1995 Sep; 172(3):810-6. PubMed ID: 7658075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]